Jennifer Larson - 12 Aug 2026 Form 4 Insider Report for Bicara Therapeutics Inc. (BCAX)

Reporting relationship: Chief Financial Officer
Issuer ticker: BCAX
Reported as of: 12 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Aug 2026, 16:54:34 UTC
Source filing: View source filing
Reporting owner signature: /s/ Ryan Cohlhepp, Attorney-in-Fact

Key filing fact

Jennifer Larson filed Form 4 for Bicara Therapeutics Inc. (BCAX) on 14 Aug 2026.

Key facts

This page summarizes Jennifer Larson's Form 4 filing for Bicara Therapeutics Inc. (BCAX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 14 Aug 2026, 16:54.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002149587 Primary reporting owner

Larson Jennifer

Relationship: Chief Financial Officer
Address: BICARA THERAPEUTICS INC., 116 HUNTINGTON AVENUE, SUITE 703, BOSTON
Signature: /s/ Ryan Cohlhepp, Attorney-in-Fact
Signature date: 14 Aug 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BCAX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +285,000
Change %
Price: $0.000000^*
Shares after: 285,000
Date: 12 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 285,000
Exercise price: $24.63
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

25% of the shares subject to this option vest and become exercisable on August 12, 2027, with the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.